SCHEMBL13487709

SCHEMBL13487709

Cn1c2ccccc2c2cc(-c3c4ccccc4c(-c4ccc5c(c4)-c4ccccc4C5(C)C)c4cc(-c5ccc6ccccc6c5)ccc34)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
HSD17B10 Q99714 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.37
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
GPR3 P46089 1/20 0.34
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
CAMK2D Q13557 1/20 0.32
KIF11 P52732 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488087 0.94 KDM4E (0.37) KDM4EHSD17B10L3MBTL1MAPTALDH1A1
SCHEMBL13487552 0.90 RXRA (0.43) KDM4EHSD17B10L3MBTL1MAPTALDH1A1
SCHEMBL13487817 0.90 RXRA (0.38) KDM4EHSD17B10L3MBTL1MAPTALDH1A1
SCHEMBL13487312 0.90 KDM4E (0.36) KDM4EHSD17B10L3MBTL1MAPTALDH1A1
SCHEMBL13487633 0.89 MAPT (0.35) KDM4EHSD17B10L3MBTL1MAPTALDH1A1
SCHEMBL13487673 0.88 TUBB4A (0.33) CAMK2DTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL22906559 0.88 GPR3 (0.44) KDM4EHSD17B10L3MBTL1MAPTALDH1A1
SCHEMBL13487478 0.87 BCHE (0.39) KDM4EHSD17B10L3MBTL1MAPTALDH1A1
SCHEMBL13488165 0.87 RXRA (0.40) KDM4EHSD17B10L3MBTL1MAPTALDH1A1
SCHEMBL13428000 0.85 TUBB4A (0.32) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 KDM4E 3671/4885HSD17B10 679/4885L3MBTL1 1193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.